drugset / Trial / NCT01476267
A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers
NaSingle-groupOpen-labelOther
Summary
This single center, open-label, non-randomized, one-treatment, one-period study will evaluate the metabolic profile and the safety of a single oral radiolabeled dose of dalcetrapib in male healthy volunteers.
Timeline
- Start
- 2011-10
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalcetrapib | Small molecule | — | Oral |
Indications
No indication recorded.